Skip to main content
Premium Trial:

Request an Annual Quote

DNASTAR, 454 Life Sciences, Illumina, Sanger, Tripos

Premium
DNASTAR has introduced its SeqMan Genome Assembler software, which enables researchers to assemble fragment data sequenced using next-generation instruments made by 454 Life Sciences, Illumina, and traditional Sanger technologies.
 
SeqMan Genome Assembler integrates with DNASTAR’s existing Lasergene suite of sequence-analysis software, allowing users to assemble and analyze sequences on Windows and Macintosh platforms.
 
The software permits users to work with multiple platforms in the same project and allows them to perform alignments and SNP discoveries, among other analyses, on de novo or templated assemblies or with resequencing projects, the company said.
 

 
Tripos has released its SYBYL 8.0 discovery research product. The upgrade has been designed to optimize processes and workflow, the company said in a statement.
 
SYBYL 8.0 contains tools designed to optimize structures as well as visualize and compare molecular models and structures. Other parts allow enhanced visualization capability and searching capabilities for lead identification tailored to accelerate and simplify the discovery process.
 
SYBYL 8.0 “enables data to be associated directly with visualized structures, and among many other benefits, includes capability for ligand- and receptor-based designs," according to Tripos development manager John Begemann.

Filed under

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.